SUCCESS PTA Study generates ‘best data we have’ on sirolimus in peripheral arterial disease patients

Disappointing presentation. He declared no conflicts of interest. The trial was not randomised and to be honest he should have pointed that out.
Very misleading and economical with the truth. This was essentially a safety study and there was no comparison (RANDOMISED) arm with paclitaxel.